幽门螺杆菌根除后上消化道出血的长期风险:基于人群的队列研究
结果显示根除者上消化道出血发生率高于阴性对照(20.8 vs 13.6/万人年),风险比1.65,且2年后风险进一步升高(HR 2.18);年龄>45岁者根除后风险仍较高。
要点
- 幽门螺杆菌根除后长期上消化道出血风险仍高于阴性对照(HR 1.65)。
- 根除后2年起出血风险升高更明显(HR 2.18)。
- 年龄>45岁患者根除后出血风险仍较高,保护作用有限。
核心结论
- 尽管接受幽门螺杆菌根除治疗,患者长期上消化道出血风险仍高于幽门螺杆菌阴性对照。
- 根除治疗预防上消化道出血的保护作用似乎仅限于年轻患者及根除后2年内。
研究设计与样本
- 基于人群的队列研究,纳入2003–2012年接受含克拉霉素三联疗法根除幽门螺杆菌且后续无需再治疗的患者。
- 采用倾向评分匹配的幽门螺杆菌阴性内镜队列作为对照。
主要发现
- 上消化道出血发生率在根除组为20.8/万人年(95%CI 19.5–22.1),阴性对照组为13.6/万人年(95%CI 12.7–14.7)。
- 与阴性对照相比,根除组上消化道出血风险显著升高(HR 1.65,95%CI 1.49–1.83)。
- 根除组随访2年后上消化道出血风险升高(HR 2.18,95%CI 1.91–2.49)。
- 年龄分层分析显示>45岁患者根除后上消化道出血风险仍较高。
临床怎么用
- 对幽门螺杆菌根除后的患者,尤其是年龄>45岁者,应关注长期上消化道出血风险。
- 根除后2年内可能仍有一定保护作用,但2年后风险升高,需考虑长期监测策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The long-term effects of H. pylori eradication in preventing upper GI bleeding (UGIB) remains unknown. AIM: To determine the long-term risks of UGIB after H. pylori eradication METHODS: We included all patients who had received clarithromycin-containing triple therapy for the treatment of H. pyliori infection between 2003 and 2012, without subsequent need for re-treatment. We included a propensity score (PS)-matched endoscopy cohort of H. pylori-negative patients as controls. The primary endpoint was the risk of subsequent UGIB. A multivariable Cox model was used to compute the hazard ratio (HR) of UGIB. RESULTS: We included 62 738 H. pylori-eradicated and 62 738 PS-matched H. pylori-negative patients, with a median follow-up of 8.1 years (IQR 5.5-10.6). The incidence of UGIB was 20.8 (95% CI 19.5-22.1) and 13.6 (95% CI 12.7-14.7) per 10 000 person-years in H. pylori-eradicated and H. pylori-negative patients, respectively. Compared to controls, H. pylori-eradicated patients had a significantly higher risk of UGIB (HR: 1.65, 95% CI 1.49-1.83). The risk of UGIB in H. pylori-eradicated patients increased after the first 2 years of follow up (HR: 2.18, 95% CI 1.91-2.49). Age-stratified analysis showed that patients >45 years had higher UGIB risk, even after eradication. CONCLUSIONS: Despite H. pylori eradication, the long-term risk of UGIB was still higher than in H. pylori-negative control subjects. The protective effects of eradication therapy in preventing UGIB appeared to be limited to younger patients, and to within the first 2 years after eradication.
引用
- Jiang F, Guo CG, Cheung KS, et al. Long-term risk of upper gastrointestinal bleeding after Helicobacter pylori eradication: a population-based cohort study. Aliment Pharmacol Ther. 2021. PMID: 34528716. doi:10.1111/apt.16604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。